The formulation brings together two peptides with complementary mechanistic profiles within the growth-hormone (somatotropic) axis: CJC-1295 with DAC, a growth-hormone-releasing hormone (GHRH) analogue carrying a drug-affinity complex that binds serum albumin and markedly extends its persistence relative to the unconjugated form, for GHRH-receptor signalling studies
These effects occur because growth hormone binds to receptors in muscle, liver, and adipose tissue, altering insulin signaling pathways and glucose uptake
The science behind this pairing is not complicated once you understand how each compound works independently, and this guide breaks down everything you need to know about combining them safely, timing your doses correctly, and understanding what realistic results actually look like
Blazejova K, Illnerova H, Hajek I, Nevsimalova S
Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization, and drug release